Home
About SinovacProductsPipelineInvestorsContact Us
 
 
  SITEMAP 中文版
  Investors
IR Home
President Message
Corporate Governance
Social Responsibility
Press Releases
Media Report
SEC Filings
Analyst Coverage
FAQs
Home Page
 
Sinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on the research, development, manufacture and commercialization of vaccines that protect against human infectious diseases. Sinovac's vaccines include Healive®(hepatitis A), Bilive®(combined hepatitis A and B) and Anflu®(influenza). Sinovac is currently developing human vaccines against the H5N1 strain of pandemic influenza, Japanese encephalitis and SARS.
Copyright © 2001-2008 Sinovac Biotech Ltd. All rights reserved.